MYC and cervical carcinoma: Furthermore, we detected that c-Myc expression was statistically higher in the chemotherapy-response group than in the non-response group, suggesting a higher level of c-Myc to be a potential predictive biomarker for cisplatin chemosensitivity in cervical cancer.